CytoDyn Inc. (CYDY)
OTCMKTS: CYDY · Delayed Price · USD
0.141
-0.001 (-0.35%)
Jul 26, 2024, 3:59 PM EDT - Market closed
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $149.26 million as of July 26, 2024. Its market cap has decreased by -37.84% in one year.
Market Cap
149.26M
Enterprise Value
178.34M
1-Year Change
-37.84%
Ranking
n/a
Category
Stock Price
$0.14
Market Cap Chart
Since July 29, 2019, CytoDyn's market cap has decreased from $167.21M to $149.26M, a decrease of -10.74%. That is a compound annual growth rate of -2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 138.49M | -23.42% |
| Dec 29, 2023 | 180.83M | -3.43% |
| Dec 30, 2022 | 187.25M | -72.81% |
| Dec 31, 2021 | 688.66M | -77.89% |
| Dec 31, 2020 | 3.11B | 620.79% |
| Dec 31, 2019 | 432.11M | 158.42% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 817.23B |
| Novo Nordisk | 593.43B |
| UnitedHealth Group | 515.19B |
| Johnson & Johnson | 376.12B |
| Merck & Co. | 318.93B |
| AbbVie | 311.16B |
| AstraZeneca | 247.14B |
| Thermo Fisher | 219.38B |